X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2766) 2766
Publication (397) 397
Book Review (51) 51
Book Chapter (24) 24
Book / eBook (17) 17
Conference Proceeding (5) 5
Dissertation (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1937) 1937
index medicus (1521) 1521
oncology (1470) 1470
glioblastoma (922) 922
recurrent glioblastoma (912) 912
female (868) 868
clinical neurology (858) 858
male (833) 833
middle aged (723) 723
adult (687) 687
brain neoplasms - drug therapy (673) 673
chemotherapy (673) 673
cancer (618) 618
aged (590) 590
phase-ii trial (590) 590
temozolomide (572) 572
glioblastoma multiforme (513) 513
radiotherapy (507) 507
brain neoplasms - pathology (494) 494
gliomas (494) 494
glioma (487) 487
bevacizumab (478) 478
animals (472) 472
glioblastoma - drug therapy (453) 453
malignant glioma (449) 449
brain neoplasms - therapy (413) 413
surgery (411) 411
survival (406) 406
medicine & public health (392) 392
glioblastoma-multiforme (387) 387
treatment outcome (384) 384
recurrent (370) 370
tumors (368) 368
radiation-therapy (364) 364
brain tumors (352) 352
recurrent malignant glioma (343) 343
care and treatment (342) 342
newly-diagnosed glioblastoma (342) 342
high-grade gliomas (337) 337
glioblastoma - pathology (330) 330
phase-ii (329) 329
prognosis (309) 309
brain-tumors (304) 304
antineoplastic agents - therapeutic use (299) 299
glioma - drug therapy (297) 297
dacarbazine - analogs & derivatives (281) 281
malignant gliomas (275) 275
brain neoplasms - mortality (270) 270
neurology (270) 270
recurrent glioblastoma-multiforme (259) 259
combined modality therapy (257) 257
glioma - pathology (257) 257
therapy (255) 255
adjuvant temozolomide (254) 254
radiology, nuclear medicine & medical imaging (249) 249
glioblastoma - therapy (248) 248
magnetic resonance imaging (243) 243
research (239) 239
retrospective studies (234) 234
recurrent malignant gliomas (233) 233
pharmacology & pharmacy (228) 228
immunotherapy (219) 219
brain neoplasms - surgery (216) 216
high-grade glioma (216) 216
neurosciences (214) 214
survival analysis (211) 211
brain cancer (210) 210
angiogenesis (208) 208
brain neoplasms - radiotherapy (207) 207
health aspects (207) 207
glioblastoma - mortality (202) 202
cell line, tumor (200) 200
clinical trials (199) 199
brain (198) 198
glioma - therapy (198) 198
analysis (196) 196
multiforme (196) 196
adolescent (195) 195
young adult (194) 194
article (184) 184
central-nervous-system (181) 181
angiogenesis inhibitors - therapeutic use (178) 178
disease-free survival (178) 178
mice (176) 176
neoplasm recurrence, local - drug therapy (175) 175
brain neoplasms - genetics (174) 174
antineoplastic combined chemotherapy protocols - therapeutic use (173) 173
radiation therapy (173) 173
trial (170) 170
survival rate (168) 168
endothelial growth-factor (166) 166
development and progression (163) 163
dacarbazine - therapeutic use (161) 161
medicine, research & experimental (159) 159
review (159) 159
patients (158) 158
clinical trials as topic (156) 156
aged, 80 and over (155) 155
brain neoplasms - metabolism (155) 155
disease progression (153) 153
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2724) 2724
French (32) 32
German (25) 25
Japanese (8) 8
Spanish (7) 7
Czech (2) 2
Korean (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 11/2013, Volume 310, Issue 17, pp. 1842 - 1850
Journal Article
JAMA, ISSN 0098-7484, 12/2015, Volume 314, Issue 23, pp. 2535 - 2543
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2014, Volume 370, Issue 8, pp. 709 - 722
In patients with glioblastoma, the addition of bevacizumab to radiotherapy and temozolomide induction therapy and the use of bevacizumab maintenance therapy... 
CONCOMITANT RADIOCHEMOTHERAPY | MEDICINE, GENERAL & INTERNAL | PHASE-II TRIAL | RECURRENT GLIOBLASTOMA | CLINICAL-TRIALS | MALIGNANT GLIOMAS | QUALITY-OF-LIFE | RESPONSE ASSESSMENT CRITERIA | MULTIFORME | HIGH-GRADE GLIOMA | ENDOTHELIAL GROWTH-FACTOR | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Induction Chemotherapy | Male | Glioblastoma - radiotherapy | Bevacizumab | Young Adult | Dacarbazine - analogs & derivatives | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Brain Neoplasms - mortality | Brain Neoplasms - radiotherapy | Angiogenesis Inhibitors - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Kaplan-Meier Estimate | Combined Modality Therapy | Brain Neoplasms - drug therapy | Disease-Free Survival | Quality of Life | Aged | Glioblastoma - drug therapy | Glioblastoma - mortality | Dosage and administration | Research | Temozolomide | Drug therapy, Combination | Drug therapy | Glioblastoma multiforme | Nuclear magnetic resonance--NMR | Intravenous administration | Glucocorticoids | Brain cancer | Body weight | Glioblastoma | Radiation therapy | Survival | Patients | Quality of life | Vascular endothelial growth factor | Index Medicus | Abridged Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2014, Volume 370, Issue 8, pp. 699 - 708
Journal Article